These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30393376)
1. Foundation of the Newborn Screening Translational Research Network and its tools for research. Lloyd-Puryear M; Brower A; Berry SA; Brosco JP; Bowdish B; Watson MS Genet Med; 2019 Jun; 21(6):1271-1279. PubMed ID: 30393376 [TBL] [Abstract][Full Text] [Related]
2. Charting the Ethical Frontier in Newborn Screening Research: Insights from the NBSTRN ELSI Researcher Needs Survey. Unnikumaran Y; Lietsch M; Brower A Int J Neonatal Screen; 2024 Sep; 10(3):. PubMed ID: 39311366 [TBL] [Abstract][Full Text] [Related]
3. Special issue: Newborn screening research. Brower A; Chan K Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):135-137. PubMed ID: 36214312 [TBL] [Abstract][Full Text] [Related]
4. Parental permission for pilot newborn screening research: guidelines from the NBSTRN. Botkin JR; Lewis MH; Watson MS; Swoboda KJ; Anderson R; Berry SA; Bonhomme N; Brosco JP; Comeau AM; Goldenberg A; Goldman E; Therrell B; Levy-Fisch J; Tarini B; Wilfond B; Pediatrics; 2014 Feb; 133(2):e410-7. PubMed ID: 24394680 [TBL] [Abstract][Full Text] [Related]
5. NBSTRN Tools to Advance Newborn Screening Research and Support Newborn Screening Stakeholders. Chan K; Hu Z; Bush LW; Cope H; Holm IA; Kingsmore SF; Wilhelm K; Scharfe C; Brower A Int J Neonatal Screen; 2023 Oct; 9(4):. PubMed ID: 37987476 [TBL] [Abstract][Full Text] [Related]
6. Accelerating the Pace of Newborn Screening Research to Advance Disease Understanding and Improve Health Outcomes:: Key Efforts of the Newborn Screening Translational Research Network (NBSTRN). Brower A; Chan K; Taylor J; Wiebenga R; Tona G; Unnikumaran Y; Barnes L Dela J Public Health; 2021 Dec; 7(5):36-37. PubMed ID: 35619984 [TBL] [Abstract][Full Text] [Related]
7. Including ELSI research questions in newborn screening pilot studies. Goldenberg AJ; Lloyd-Puryear M; Brosco JP; Therrell B; Bush L; Berry S; Brower A; Bonhomme N; Bowdish B; Chrysler D; Clarke A; Crawford T; Goldman E; Hiner S; Howell RR; Orren D; Wilfond BS; Watson M; Genet Med; 2019 Mar; 21(3):525-533. PubMed ID: 30100612 [TBL] [Abstract][Full Text] [Related]
8. Early Check: translational science at the intersection of public health and newborn screening. Bailey DB; Gehtland LM; Lewis MA; Peay H; Raspa M; Shone SM; Taylor JL; Wheeler AC; Cotten M; King NMP; Powell CM; Biesecker B; Bishop CE; Boyea BL; Duparc M; Harper BA; Kemper AR; Lee SN; Moultrie R; Okoniewski KC; Paquin RS; Pettit D; Porter KA; Zimmerman SJ BMC Pediatr; 2019 Jul; 19(1):238. PubMed ID: 31315600 [TBL] [Abstract][Full Text] [Related]
9. Considerations in choosing screening conditions: one (US) approach. Therrell BL Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):22-5. PubMed ID: 19904477 [TBL] [Abstract][Full Text] [Related]
10. Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders. Osara Y; Coakley K; Devarajan A; Singh RH Orphanet J Rare Dis; 2017 Jul; 12(1):132. PubMed ID: 28724394 [TBL] [Abstract][Full Text] [Related]
11. Newborn screening conditions: What we know, what we do not know, and how we will know it. Levy HL Genet Med; 2010 Dec; 12(12 Suppl):S213-4. PubMed ID: 21150366 [TBL] [Abstract][Full Text] [Related]
12. Expert Evaluation of Strategies to Modernize Newborn Screening in the United States. Bailey DB; Porter KA; Andrews SM; Raspa M; Gwaltney AY; Peay HL JAMA Netw Open; 2021 Dec; 4(12):e2140998. PubMed ID: 34964853 [TBL] [Abstract][Full Text] [Related]
13. Genetics professionals' opinions of whole-genome sequencing in the newborn period. Ulm E; Feero WG; Dineen R; Charrow J; Wicklund C J Genet Couns; 2015 Jun; 24(3):452-63. PubMed ID: 25348082 [TBL] [Abstract][Full Text] [Related]
15. Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America. Giugliani R J Inherit Metab Dis; 2012 Sep; 35(5):871-7. PubMed ID: 22231381 [TBL] [Abstract][Full Text] [Related]
16. Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs. De Jesús VR; Adam BW; Mandel D; Cuthbert CD; Matern D Mol Genet Metab; 2014; 113(1-2):67-75. PubMed ID: 25066104 [TBL] [Abstract][Full Text] [Related]
17. Newborn screening for proximal urea cycle disorders: Current evidence supporting recommendations for newborn screening. Merritt JL; Brody LL; Pino G; Rinaldo P Mol Genet Metab; 2018 Jun; 124(2):109-113. PubMed ID: 29703588 [TBL] [Abstract][Full Text] [Related]
18. Landscape Analysis of Neurodevelopmental Comorbidities in Newborn Screening Conditions: Challenges and Opportunities. Talebizadeh Z; Hu V; Shababi M; Brower A Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38248632 [TBL] [Abstract][Full Text] [Related]
19. The Longitudinal Pediatric Data Resource: Facilitating Longitudinal Collection of Health Information to Inform Clinical Care and Guide Newborn Screening Efforts. Brower A; Chan K; Hartnett M; Taylor J Int J Neonatal Screen; 2021 Jun; 7(3):. PubMed ID: 34208910 [TBL] [Abstract][Full Text] [Related]
20. Impact of expanded newborn screening--United States, 2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(37):1012-5. PubMed ID: 18802410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]